Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies

J Clin Endocrinol Metab. 2003 Aug;88(8):3474-81. doi: 10.1210/jc.2003-030185.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antithyroid Agents / adverse effects
  • Antithyroid Agents / economics
  • Antithyroid Agents / therapeutic use*
  • Clinical Trials as Topic
  • Evidence-Based Medicine
  • Expert Testimony
  • Female
  • Graves Disease / drug therapy*
  • Graves Disease / radiotherapy
  • Humans
  • Iodine Radioisotopes / therapeutic use
  • MEDLINE
  • Methimazole / adverse effects
  • Methimazole / economics
  • Methimazole / therapeutic use
  • Middle Aged
  • Patient Compliance
  • Propylthiouracil / adverse effects
  • Propylthiouracil / economics
  • Propylthiouracil / therapeutic use
  • Randomized Controlled Trials as Topic
  • Thyroid Function Tests

Substances

  • Antithyroid Agents
  • Iodine Radioisotopes
  • Methimazole
  • Propylthiouracil